Abstract | OBJECTIVE: To examine the impact of a policy restricting reimbursement for Medicaid anti-ulcer drugs on anti- ulcer drug use and peptic-related hospitalizations. DATA SOURCES/STUDY SETTING: In addition to U.S. Census Bureau data, all of the following from Florida: Medicaid anti- ulcer drug claims data, 1989-1993; Medicaid eligibility data, 1989-1993; and acute care nonfederal hospital discharge abstract data (Medicaid and non-Medicaid), 1989-1993. STUDY DESIGN: In this observational study, a Poisson multiple regression model was used to compare changes, after policy implementation, in Medicaid reimbursement for prescription anti-ulcer drugs as well as hospitalization rates between pre- and post-implementation periods in Medicaid versus non-Medicaid patients hospitalized with peptic ulcer disease. PRINCIPAL FINDINGS: Following policy implementation, the rate of Medicaid reimbursement for anti-ulcer drugs decreased 33 percent (p < .001). No associated increase occurred in the rate of Medicaid peptic-related hospitalizations. CONCLUSIONS: Florida's policy restricting Medicaid reimbursement for anti-ulcer drugs was associated with a substantial reduction in outpatient anti- ulcer drug utilization without any significant increase in the rate of hospitalization for peptic-related conditions.
|
Authors | D M Cromwell, E B Bass, E P Steinberg, Y Yasui, W J Ravich, T R Hendrix, S F McLeod, R D Moore |
Journal | Health services research
(Health Serv Res)
Vol. 33
Issue 6
Pg. 1593-610
(Feb 1999)
ISSN: 0017-9124 [Print] United States |
PMID | 10029499
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Anti-Ulcer Agents
(economics, therapeutic use)
- Child
- Child, Preschool
- Cost Control
- Drug Costs
(statistics & numerical data)
- Drug Utilization
- Female
- Florida
- Hospitalization
(statistics & numerical data, trends)
- Humans
- Infant
- Male
- Medicaid
(economics)
- Middle Aged
- Organizational Policy
- Peptic Ulcer
(drug therapy, economics)
- Regression Analysis
- Reimbursement Mechanisms
(economics, statistics & numerical data, trends)
- United States
|